CXCL10 and ovarian carcinoma: In Bell et al. [8], ovarian cancer was classified into four ovarian cancer subtypes depending on the expression levels of marker genes: “immunoreactive,” “proliferative,” “differentiated,” and “mesenchymal.” The immunoreactive subtype was identified by the chemokine receptor CXCR3 and its ligands CXCL11 and CXCL10, indicating that considerable expression changes of these genes are important markers for identifying the subtype.